Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery

BACKGROUND: To prevent risk of life-threatening stent thrombosis, all patients need to undergo dual antiplatelet therapy (DAPT) for at least 6 weeks to 12 months after stent implantation. If DAPT is continued during noncardiac surgery, there is a risk of severe bleeding at the surgical site. Our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, San-Bao, Hai, Yong, Tang, Jie-Fu, Liu, Tao, Liang, Bing-Xin, Xue, Bo-Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595756/
https://www.ncbi.nlm.nih.gov/pubmed/30958436
http://dx.doi.org/10.1097/CM9.0000000000000186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595756/
https://www.ncbi.nlm.nih.gov/pubmed/30958436
http://dx.doi.org/10.1097/CM9.0000000000000186

Ejemplares similares